Careers  |  Sign In  |  Register

Latest in Internal Medicine

Fails to alleviate moderate persistent asthma symptoms

Mepolizumab Fails in a Phase II Trial

Mepolizumab, an IL-5 inhibitor, failed to alleviate moderate persistent asthma symptoms in a phase II trial of patients resistant to corticosteroids. References and Resources Flood-Page P, Swenson C, Faiferman I. A Study to Evaluate Safety and Efficacy of Mepolizumab in Patients with Moderate...

Optimizing patient outcomes

Liver Transplantation

Douglas P. Slakey, MD, MPH, Regents Professor and Chair, Department of Surgery, Tulane University School of Medicine, discusses optimizing transplant patient outcomes. References and Resources American Liver Foundation Click Here to read information on liver transplantation. Liver &...